Avalanche Biotechnologies, an early-stage biotech developing gene therapies for wet AMD and other ophthalmic diseases, filed on Monday with the SEC to raise up to $86 million in an initial public offering. The Menlo Park, CA-based company, which was founded in...read more
Applied Genetic Technologies, a biotech developing gene therapies for orphan eye diseases, raised $50 million by offering 4.2 million shares at $12, below its proposed $13 to $15 range. The Alachua, FL-based company originally filed to sell 3.6 million shares....read more
Castlight Health (CSLT) completed the fourth technology IPO of the year, and its 149% first day return brought the sector's average up to 95% for 2014. Castlight was also the ...read more
Eye disease biotech Avalanche Biotechnologies files for a $86 million IPO
Avalanche Biotechnologies, an early-stage biotech developing gene therapies for wet AMD and other ophthalmic diseases, filed on Monday with the SEC to raise up to $86 million in an initial public offering. The Menlo Park, CA-based company, which was founded in...read more
Biotech Applied Genetic Technologies prices IPO at $12, below the range
Applied Genetic Technologies, a biotech developing gene therapies for orphan eye diseases, raised $50 million by offering 4.2 million shares at $12, below its proposed $13 to $15 range. The Alachua, FL-based company originally filed to sell 3.6 million shares....read more
9 US IPOs planned for the week of Mar 24
The following IPOs are expected to price this week: 2U (TWOU), a cloud-based platform for online degree programs at nonprofit universities, plans to raise $110 million...read more
US IPO Recap: Castlight Health's 149% pop shows healthy tech demand
Castlight Health (CSLT) completed the fourth technology IPO of the year, and its 149% first day return brought the sector's average up to 95% for 2014. Castlight was also the ...read more